From Pharma PRs Synthetic Biologics En
Post# of 63700
- Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
1:30 pm - PR Newswire Saturday 7th
SYN Chart